Yifeng Pharmacy Chain Co., Ltd. Stock

Equities

603939

CNE100001TS5

Drug Retailers

End-of-day quote Shanghai S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
46.14 CNY -0.15% Intraday chart for Yifeng Pharmacy Chain Co., Ltd. +1.54% +15.23%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 27.68B 3.83B Sales 2025 * 33.88B 4.69B Capitalization 46.63B 6.46B
Net income 2024 * 1.78B 246M Net income 2025 * 2.18B 301M EV / Sales 2024 * 1.56 x
Net cash position 2024 * 3.41B 472M Net cash position 2025 * 7.27B 1.01B EV / Sales 2025 * 1.16 x
P/E ratio 2024 *
26.2 x
P/E ratio 2025 *
21.4 x
Employees -
Yield 2024 *
1.07%
Yield 2025 *
1.31%
Free-Float 45.08%
More Fundamentals * Assessed data
Dynamic Chart
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Yifeng Pharmacy Chain Lists 1.80 Billion Yuan Worth of Convertible Bonds on Shanghai Bourse MT
Nomura Adjusts Yifeng Pharmacy Chain’s Price Target to 49.56 Yuan From 48.61 Yuan, Keeps at Buy MT
Yifeng Pharmacy Chain Co., Ltd.(SHSE:603939) added to Shanghai Stock Exchange 180 Value Index CI
Yifeng Pharmacy Chain Co., Ltd.(SHSE:603939) added to SSE 180 Index CI
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Yifeng Pharmacy Chain's Price Target to 48.61 Yuan From 50.32 Yuan, Keeps at Buy MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Breakfast for 40 cents: what China's deflation looks like RE
Nomura Adjusts Yifeng Pharmacy's Price Target to 50.32 Yuan From 48.99 Yuan, Keeps at Buy MT
Shanghai Bourse Defers Review of Yifeng Pharmacy Chain’s Bond Sale Application MT
Nomura Starts Yifeng Pharmacy Chain at Buy With 68.58 Yuan Price Target MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yifeng Pharmacy Chain to Sell 2.5 Billion Yuan Bonds for Expansion Plans MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
More news
1 day-0.15%
1 week+1.54%
Current month+5.01%
1 month+7.73%
3 months+8.23%
6 months+18.55%
Current year+15.23%
More quotes
1 week
44.80
Extreme 44.8
46.82
1 month
41.30
Extreme 41.3
46.82
Current year
36.90
Extreme 36.9
46.82
1 year
30.90
Extreme 30.9
46.82
3 years
22.46
Extreme 22.4643
52.50
5 years
22.17
Extreme 22.1743
60.57
10 years
5.50
Extreme 5.5024
60.57
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 08-05-31
Director of Finance/CFO 44 19-10-28
Chief Operating Officer 29 17-06-30
Members of the board TitleAgeSince
Director/Board Member 57 08-12-31
Director/Board Member 55 21-03-28
Chief Executive Officer 55 08-05-31
More insiders
Date Price Change Volume
24-05-14 46.14 -0.15% 2,993,524
24-05-13 46.21 +0.39% 3,817,834
24-05-10 46.03 -1.29% 4,972,959
24-05-09 46.63 +3.58% 5,032,507
24-05-08 45.02 -0.92% 2,765,539

End-of-day quote Shanghai S.E., May 13, 2024

More quotes
Yifeng Pharmacy Chain Co Ltd is a China-based company principally engaged in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The Company mainly operates through retailing segment. The Company operates direct pharmaceutical chain stores mainly in provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The Company is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
46.14 CNY
Average target price
52.74 CNY
Spread / Average Target
+14.30%
Consensus
  1. Stock Market
  2. Equities
  3. 603939 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW